KIR3DL1 and lymphoproliferative syndrome: Overall, the number of inhibitor KIR genes was found to be higher in lymphoproliferative disorder patients than in other groups (Table 6), and simultaneously lymphoproliferative disorders showed a reduction in NK activation due to a lower frequency of the activator KIR genes KIR2DS3 and KIR2DS5 (Fig. 3).